L.E.K. Insights | L.E.K. Consulting

Life Sciences & Pharma

2021 Asia-Pacific (APAC) Digital Readiness for the Healthcare Sector

February 26, 2021

The digital health landscape is transforming rapidly; L.E.K. Consulting and Galen Growth evaluated APAC countries.

Consumer Services

The Path to Recovery — Edition 2

September 1, 2020

As the impact of COVID-19 continues for Australia, it seems difficult to predict when or how consumer confidence, spending and lifestyle can uniformly…

Life Sciences & Pharma

COVID-19 Implications for Biopharma

June 25, 2020

This report highlights how biopharma executives should adapt to the evolving biopharma landscape in both the nearer and longer term.

Life Sciences & Pharma

COVID-19 Therapeutic Research and Development Landscape

June 3, 2020

The following materials provide a snapshot of the unprecedented scope and speed of biopharma’s therapeutics research and development (R&D) response to…

Consumer Products

Paths to Recovery, Planning for Recession and the New Normal

May 22, 2020

As certain parts of the country start to reopen or consider reopening, it is natural to look ahead. In this report, we will address some of the questions…

Consumer Services

COVID-19: Setting the Path for Recovery

May 6, 2020

Australia's actions over coming months will be key to setting the ultimate path for recovery